Polymorphism of IL-1α, IL-1β and IL-10 in patients with advanced ovarian cancer: Results of a prospective study with 147 patients

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 680-685

  Ioana Braicu, Elena ^a,b   Mustea, Alexander ^a   Toliat, Mohammad R ^c   Pirvulescu, Cristina ^a   Könsgen, Dominique ^a   Sun, Pengming ^a,d   Nürnberg, Peter ^c   Lichtenegger, Werner ^a   Sehouli, Jalid ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF COLOGNE   (Germany)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Cytokines; IL 10; IL 1 ; IL 1 ; Ovarian cancer; Polymorphism

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SAMPLE SIZE; SEQUENCE ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UNIVARIATE ANALYSIS; CANCER STAGING; GENETICS; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33846919143     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.014     Document Type: Article

References (32)

1. Landis S.H., Murray T., Bolden S., and Wingo P.A. Cancer statistics. CA Cancer J. Clin. 49 1 (1999) 8-31
2. In: DeVita Jr. V.T., Hellman S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 4th ed. (1993), JB Lippincott Co, Philadelphia
3. Bushley A.W., Ferrell R., McDuffie K., Terada K.Y., Carney M.E., Thompson P.J., et al. Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecol. Oncol. 95 3 (2004) 672-679
4. Hefler L.A., Grimm C., Ackermann S., Malur S., Radjabi-Rahat A.R., Leodolter S., et al. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res. 63 12 (2003) 3066-3068
5. Moore K.W., O'Garra A., de Vaal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 11 (2003) 165-190
6. Mocellin S., Panelli M.C., Wang E., Nagorsen D., and Marincola F.M. The dual role of IL-10. Trends Immunol. 24 1 (2003) 36-43 [Review]
7. Nash M.A., Ferrandina G., Gordinier M., Loercher A., and Freedman R.S. The role of cytokines in both the normal and malignant ovary. Endocr.-Relat. Cancer 6 (1999) 93-107
8. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., McDermott M.F., et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1 1 (1999) 3-19 [Review]
9. Santin A.D., Bellone S., Ravaggi A., Roman J., Smith V., Pecorelli S., et al. Increased levels of interleukin-10 and transforming growth factor-β in the plasma and ascitic fluid of patients with advanced ovarian cancer. Br. J. Obstet. Gynecol. 108 (2001) 804-808
10. Berek J.S., and Martinez-Maza O. Molecular and biologic factors in the pathogenesis of ovarian cancer. J. Reprod. Med. 39 4 (1994) 241-248 [Review]
11. Stadlmann S., Amberger A., Pollheimer J., Gastl G., Offner F.A., Margreiter R., et al. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. Gynecol. Oncol. 97 3 (2005) 784-789
12. Zeimet A.G., Widschwendter M., Knabbe C., Fuchs D., Herold M., Muller-Holzner E., et al. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J. Clin. Oncol. 16 5 (1998) 1861-1868
13. Offner F.A., Obrist P., Stadlmann S., Feichtinger H., Klingler P., Herold M., et al. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7 6 (1995) 542-547
14. Ziltener H.J., Maines-Bandiera S., Schrader J.W., and Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol. Reprod. 49 3 (1993) 635-641
15. Hefler L.A., Ludwig E., Lebrecht A., Zeillinger R., Tong-Cacsire D., Koelbl H., et al. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J. Soc. Gynecol. Investig. 9 6 (2002) 386-390
16. Hefler L.A., Grimm C., Lantzsch T., Lampe D., Leodolter S., Koelbl H., et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in Caucasian women. Clin. Cancer Res. 11 16 (2005) 5718-5721
17. Mustea A., Sehouli J., Konsgen D., Stengel D., Sofroni D., and Lichtenegger W. Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res. 23 2A (2003) 1099-1102
18. Kamangar F., Abnet C.C., Hutchinson A.A., Newschaffer C.J., Helzlsouer K., Shugart Y.Y., et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17 1 (2006) 117-125
19. Sehouli J., Mustea A., Konsgen D., Katsares I., and Lichtenegger W. Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res. 22 6A (2002) 3421-3424 [Review]
20. Tang R.F., Wang S.X., Zhang F.R., Peng L., Wang S.X., Xiao Y., et al. Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer. Hepatobiliary Pancreat. Dis. Int. 4 3 (2005) 460-463
21. Graziano F., Ruzzo A., Santini D., Humar B., Tonini G., Catalano V., et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J. Clin. Oncol. 23 10 (2005) 2339-2345
22. Jia S.F., Zwelling L.A., McWatters A., An T., and Kleinerman E.S. Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells. J. Exp. Ther. Oncol. 2 1 (2002) 27-36
23. Lee K.M., Park S.K., Hamajima N., Tajima K., Choi J.Y., Noh D.Y., et al. Genetic polymorphisms of interleukin-1 beta (IL-1β) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res. Treat. 30 (2005) 1-6
24. Pisa P., Halapi E., Pisa K., Gerdin E., Hising C., Bucht A., et al. Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Immunology 89 (1992) 7708-7712
25. Stanczuk G.A., Sibanda E.N., Perrey C., Chirara M., Pravica V., Hutchinson I.V., et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int. J. Cancer 94 6 (2001) 792-794
26. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174 4 (1991) 915-924
27. Gianotti L., Fortis C., Braga M., Gentilini O., Vignali A., and Di Carlo V. Radical oncologic surgery affects circulatory levels of interleukin 10. J. Surg. Oncol. 66 (1997) 244-247
28. Galizia G., Oditura M., Romano C., Lieto E., Castellano P., Pelosio L., et al. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin. Immunol. 102 (2002) 169-178
29. Sehouli J., Konsgen D., Mustea A., Oskay-Ozcelik G., Katsares I., Weidemann H., et al. "IMO"-intraoperative mapping of ovarian cancer. Zentralbl. Gynaekol. 125 3-4 (2003) 129-135
30. Bristow R.E., Tomacruz R.S., Armstrong D.K., et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J. Clin. Oncol. 20 (2002) 1248-1259
31. Harter P., and du Bois A. The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence. Curr. Opin. Oncol. 17 5 (2005) 505-514
32. Sehouli J., Mustea A., Koensgen D., and Lichtenegger W. Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer. Cancer Epidemiol., Biomarkers Prev. 12 (2003) 1205-1208